Novavax, Inc. (NVAX) Financial Statements (2024 and earlier)

Company Profile

Business Address 700 QUINCE ORCHARD ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,336,8831,515,116711,04778,82392,134157,303
Cash and cash equivalents1,336,8831,515,116553,39878,82370,154106,307
Short-term investments   157,649 21,98050,996
Restricted cash and investments10,30311,49093,8802,94710,84728,234
Receivables  454,993262,0127,500  
Inventory, net of allowances, customer advances and progress billings36,683     
Inventory36,683     
Prepaid expense 160,773120,029171,6024,37611,97413,085
Other current assets 76,37453,4919,6623,6014,3214,689
Other undisclosed current assets82,375     
Total current assets:1,703,3912,155,1191,248,20397,247119,276203,311
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 69,857   
Operating lease, right-of-use asset 36,384   
Property, plant and equipment294,247228,696179,95411,44528,42635,987
Intangible assets, net (including goodwill)126,331136,249141,10456,73558,50861,436
Goodwill126,331131,479135,37951,15451,96753,563
Intangible assets, net (excluding goodwill)  4,7705,7255,5816,5417,873
Restricted cash and investments  1,460410958890
Other noncurrent assets28,46956,68911,7587,120810869
Other undisclosed noncurrent assets      
Total noncurrent assets:555,288421,634334,27675,71088,70299,182
TOTAL ASSETS:2,258,6792,576,7531,582,479172,957207,978302,493
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities807,675800,781196,80022,85543,56140,301
Interest and dividends payable 5,0785,0785,0785,078
Employee-related liabilities   9,632 
Accounts payable216,517127,05054,3322,9109,3015,613
Accrued liabilities591,158673,731137,39014,86719,55029,610
Deferred revenue370,1371,422,944273,2281,678
Debt352,077130,533105,862   
Deferred revenue and credits25,625
Other liabilities930,05536,0613,7821,2621,6007,749
Other undisclosed current liabilities     378 
Total current liabilities:2,459,9442,390,319579,67225,79545,53973,675
Noncurrent Liabilities
Long-term debt and lease obligation197,704323,458362,118320,611319,187317,763
Long-term debt, excluding current maturities166,466323,458322,035320,611319,187317,763
Finance lease, liability31,238 40,083 
Liabilities, other than long-term debt235,109214,64913,48012,5688,68712,787
Deferred revenue and credits2,500
Deferred revenue179,414172,528 2,500
Other liabilities55,69542,12113,48010,0688,68710,287
Other undisclosed noncurrent liabilities     2,500 
Total noncurrent liabilities:432,813538,107375,598333,179330,374330,550
Total liabilities:2,892,7572,928,426955,270358,974375,913404,225
Equity
Equity, attributable to parent(634,078)(351,673)627,209(186,017)(167,935)(101,732)
Common stock8687647143243,8493,237
Treasury stock, value(90,659)(85,101)(41,806)(2,583)(2,450)(2,450)
Additional paid in capital3,737,9793,351,9672,535,4761,260,5511,140,9641,020,457
Accumulated other comprehensive income (loss)(6,377)(1,353)7,024(12,508)(11,191)(8,617)
Accumulated deficit(4,275,889)(3,617,950)(1,874,199)(1,431,801)(1,299,107)(1,114,359)
Total equity:(634,078)(351,673)627,209(186,017)(167,935)(101,732)
TOTAL LIABILITIES AND EQUITY:2,258,6792,576,7531,582,479172,957207,978302,493

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,981,8721,146,290475,59818,66234,28831,176
Revenue, net31,176
Cost of revenue(902,639)     
Cost of goods and services sold(76,686)     
Gross profit:1,079,2331,146,290475,59818,66234,28831,176
Operating expenses(1,723,969)(2,832,866)(892,317)(148,259)(208,206)(202,886)
Other undisclosed operating income    9,016  
Operating loss:(644,736)(1,686,576)(416,719)(120,581)(173,918)(171,710)
Nonoperating income (expense)10,969(6,833)13,6051,4992,7822,013
Investment income, nonoperating  1,3641,0141,5122,6741,946
Other nonoperating income (expense)10,969(8,197)12,591(13)10867
Interest and debt expense(19,880)(21,127)(15,145)(13,612)(13,612)(14,072)
Loss from continuing operations before income taxes:(653,647)(1,714,536)(418,259)(132,694)(184,748)(183,769)
Income tax expense (benefit)(4,292)(29,215)    
Loss from continuing operations:(657,939)(1,743,751)(418,259)(132,694)(184,748)(183,769)
Loss before gain (loss) on sale of properties:(1,743,751)(418,259)(132,694)(184,748)(183,769)
Net loss available to common stockholders, basic:(657,939)(1,743,751)(418,259)(132,694)(184,748)(183,769)
Interest on convertible debt      
Net loss available to common stockholders, diluted:(657,939)(1,743,751)(418,259)(132,694)(184,748)(183,769)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(657,939)(1,743,751)(418,259)(132,694)(184,748)(183,769)
Comprehensive loss:(657,939)(1,743,751)(418,259)(132,694)(184,748)(183,769)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(5,024)(8,377)19,532(1,317)(2,574)3,197
Comprehensive loss, net of tax, attributable to parent:(662,963)(1,752,128)(398,727)(134,011)(187,322)(180,572)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: